Search results
Results From The WOW.Com Content Network
Asherman's syndrome (AS) is an acquired uterine condition that occurs when scar tissue forms inside the uterus and/or the cervix. [1] It is characterized by variable scarring inside the uterine cavity, where in many cases the front and back walls of the uterus stick to one another.
post-abortion or post-miscarriage insertion occurs following an abortion or miscarriage when the uterus is known to be empty; postpartum insertion occurs after a woman gives birth either immediately, while the woman is still in the hospital, or delayed, up to 6-weeks following delivery, following either vaginal delivery or cesarean delivery .
“An IUD is recommended for any patient who is interested in a method of birth control that gives them long-term ‘set it and forget it’ pregnancy prevention, since IUDs can work for three to ...
The acute form is usually from an infection that passes through the cervix as a result of an abortion, during menstruation, following childbirth, or as a result of douching or placement of an IUD. [2] [3] Risk factors for endometritis following delivery include Caesarean section and prolonged rupture of membranes. [1]
For women undergoing a medication abortion during the second trimester, having an IUD inserted early (five to 14 days after) vs. delayed (three to four weeks after) carries a slightly higher risk ...
For premium support please call: 800-290-4726 more ways to reach us
Dilation (or dilatation) and curettage (D&C) refers to the dilation (widening or opening) of the cervix and surgical removal of sections and/or layers of the lining of the uterus and or contents of the uterus such as an unwanted fetus (early abortion before 13 weeks), remains of a non-viable fetus, retained placenta after birth or abortion as well as any abnormal tissue which may be in the ...
The IUD with progestogen is a type of long-acting reversible birth control. [5] It works by thickening the mucus at the opening of the cervix, stopping the buildup of the lining of the uterus, and occasionally preventing ovulation. [2] The IUD with levonorgestrel was first approved for medical use in 1990 in Finland and in the United States in ...